Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Varex Imaging (VREX) Cost of Revenue (2016 - 2026)

Historic Cost of Revenue for Varex Imaging (VREX) over the last 11 years, with Q1 2026 value amounting to $139.8 million.

  • Varex Imaging's Cost of Revenue rose 647.37% to $139.8 million in Q1 2026 from the same period last year, while for Jan 2026 it was $562.6 million, marking a year-over-year increase of 182.81%. This contributed to the annual value of $554.1 million for FY2025, which is 0.0% changed from last year.
  • As of Q1 2026, Varex Imaging's Cost of Revenue stood at $139.8 million, which was up 647.37% from $151.1 million recorded in Q4 2025.
  • Varex Imaging's 5-year Cost of Revenue high stood at $156.9 million for Q3 2022, and its period low was $131.3 million during Q1 2025.
  • Its 5-year average for Cost of Revenue is $143.3 million, with a median of $141.6 million in 2022.
  • As far as peak fluctuations go, Varex Imaging's Cost of Revenue skyrocketed by 1048.9% in 2023, and later crashed by 971.06% in 2024.
  • Varex Imaging's Cost of Revenue (Quarter) stood at $142.3 million in 2022, then fell by 6.61% to $132.9 million in 2023, then grew by 4.29% to $138.6 million in 2024, then grew by 9.02% to $151.1 million in 2025, then decreased by 7.48% to $139.8 million in 2026.
  • Its last three reported values are $139.8 million in Q1 2026, $151.1 million for Q4 2025, and $135.5 million during Q3 2025.